Loading organizations...
Loading organizations...
Vaccine development for fungal and bacterial infections.
NovaDigm Therapeutics has raised $14.0M across 1 funding round.
NovaDigm Therapeutics has raised $14.0M in total across 1 funding round.
NovaDigm Therapeutics has raised $14.0M in total across 1 funding round.
NovaDigm Therapeutics's investors include Domain Associates, RusnanoMedInvest.
NovaDigm Therapeutics has raised $14.0M across 1 funding round. Most recently, it raised $14.0M Series B in October 2013.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 3, 2013 | $14.0M Series B | Domain Associates, RusnanoMedInvest |